Lithium succinate

Lithium succinate
Clinical data
Other namesLithium succinate dibasic
AHFS/Drugs.comMonograph
ATC code
Identifiers
IUPAC name
  • Dilithium butanedioate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
ECHA InfoCard100.163.153
Chemical and physical data
FormulaC4H4Li2O4
Molar mass129.95 g·mol−1
3D model (JSmol)
SMILES
  • [Li+].[Li+].[O-]C(=O)CCC([O-])=O
InChI
  • InChI=1S/C4H6O4.2Li/c5-3(6)1-2-4(7)8;;/h1-2H2,(H,5,6)(H,7,8);;/q;2*+1/p-2 checkY
  • Key:WAHQBNXSPALNEA-UHFFFAOYSA-L checkY
  (verify)

Lithium succinate (C4H4Li2O4), the dilithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]

References

  1. ^ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology. 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107.
  2. ^ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International Journal of STD & AIDS. 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500. S2CID 23095115.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.